Ocean Azul Partners

Ocean Azul Partners is a venture capital firm based in Coral Gables, Florida, founded in 2017. The firm focuses on supporting early-stage companies in the business-to-business software and deep technology sectors. It targets investments primarily in North America and Israel, reflecting a commitment to fostering innovation in these regions. Ocean Azul Partners aims to assist entrepreneurs in bringing their innovative solutions to market, emphasizing the importance of advancing technology and business practices.

Kristy King

Managing Director and Co-Founder

Ryan Pruitt

Managing Director

Bill Pruitt

Managing Director and Co-Founder

Salomon Sredni

Managing Director

Lisette Tellez

Managing Director

Alex Tellez

Managing Director

David Zinn

Managing Director and Co-Founder

Past deals in Florida

Gemini Sports Analytics

Seed Round in 2022
Gemini Sports Analytics specializes in creating a data management platform tailored for sports management. The platform employs artificial intelligence-based predictive analytics tools to assist sports managers in making informed, data-driven decisions. By focusing on athlete welfare and performance enhancement, Gemini Sports Analytics aims to optimize the overall management of sports teams and organizations.

BetaBlocks

Seed Round in 2021
Betablocks is a Miami-based and VC-backed white-label digital asset platform that allows brands to offer experiences, monetize assets, and drive user engagement. Our Storefront Builder is a turnkey solution for NFT and utility token marketplace creation, and digital asset redemption, powered by a full suite of APIs. We focus on ESG use cases, including carbon credits and we have a presence in Manaus, in the heart of the Amazon Forest.

SwiftSync

Series A in 2021
SwiftSync is a medtech startup developing disposable, dual-chamber pacing catheters. The company's temporary cardiac pacing involves electrical cardiac stimulation to treat arrhythmia during surgery and emergency surgery. Its patented device is moving toward clinical trials on the road to FDA approval and commercial sales.

Itopia

Venture Round in 2021
Itopia is a desktop-as-a-service solution for Google Cloud Platform, providing an end-to-end automated and orchestrated software. Its Cloud Automation Stack (CAS) technology is an enterprise IT life-cycle management solution purpose-built for Google Cloud Platform (GCP) environments. CAS enables enterprise IT departments and service providers to rapidly migrate and on-ramp enterprise workloads to GCP, including virtual desktops and applications, graphic workstations, hybrid Active Directory (AD) environments, AD-based disaster recovery, and Windows and Linux virtual machines. CAS drastically reduces the time and cost of managing GCP infrastructure and end-user computing environments all through an intuitive single pane of the glass management portal. itopia was founded in October 2013 by Ubaldo Don and Jonathan Lieberman. It is based in Miami, Florida.

Aegle Therapeutics

Series A in 2020
Aegle Therapeutics is a privately-held biotechnology company developing a first in class therapy using extracellular vesicles, including exosomes, secreted by allogeneic bone marrow-derived mesenchymal stem cells. Aegle's platform technology is initially being developed to treat dystrophic epidermolysis bullosa, a rare pediatric skin blistering disorder. Aegle's IND for DEB has been cleared by the FDA and the company expects to enter the clinic by the 2H of 2020. Its proprietary platform isolation technology is cell-free and has the potential to demonstrate a safer, lower-cost means of harnessing the regenerative healing power of stem cells without using the cells. Aegle believes its EV therapy has the potential for functional regeneration and organization of complex tissue structures that can enhance healing, reduce scarring, minimize contraction, and improve overall cosmesis. The company was founded in 2013 and is based in Miami, Florida.

5x5 Technologies

Series B in 2020
5x5 Technologies Inc. specializes in developing unmanned aircraft systems and advanced data analytics solutions for critical infrastructure owners. Founded in 2016 and based in St. Petersburg, Florida, the company provides a software-as-a-service platform that utilizes artificial intelligence and machine learning to create accurate digital twin models of complex structures. This technology enables clients to optimize performance, automate workflows, and reduce operational costs while uncovering new revenue opportunities through enhanced portfolio-wide analytics. Trusted by leading companies, systems integrators, and governmental agencies, 5x5 Technologies combines 3D analytics with innovative system integrations, positioning itself as a leader in the unmanned aerial vehicle and data analytics sectors. The firm has a global workforce with employees across North and Central America, Europe, and Asia, and is supported by various investors, including Softbank Corp. and several innovation-driven family offices.

Aegle Therapeutics

Series A in 2020
Aegle Therapeutics is a privately-held biotechnology company developing a first in class therapy using extracellular vesicles, including exosomes, secreted by allogeneic bone marrow-derived mesenchymal stem cells. Aegle's platform technology is initially being developed to treat dystrophic epidermolysis bullosa, a rare pediatric skin blistering disorder. Aegle's IND for DEB has been cleared by the FDA and the company expects to enter the clinic by the 2H of 2020. Its proprietary platform isolation technology is cell-free and has the potential to demonstrate a safer, lower-cost means of harnessing the regenerative healing power of stem cells without using the cells. Aegle believes its EV therapy has the potential for functional regeneration and organization of complex tissue structures that can enhance healing, reduce scarring, minimize contraction, and improve overall cosmesis. The company was founded in 2013 and is based in Miami, Florida.

DadeSystems

Series D in 2019
DadeSystems, LLP specializes in developing payment processing software solutions, particularly focused on cash application automation. Its flagship product, DadePay, is a SaaS-based platform that automates the complex invoice-to-cash process, efficiently capturing incoming payments through various channels such as cash, checks, ACH, EFT, and credit cards. DadePay employs advanced algorithms to match payments to open invoices, ensuring that updates are reflected in ERP systems and facilitating electronic deposits at banks. The suite includes additional features like DadePay Mobile for mobile payment matching and a customer ePayment portal. DadeSystems serves a diverse range of industries, including manufacturing, healthcare, retail, and financial institutions, helping them improve efficiency, reduce processing costs, and enhance customer payment experiences. Founded in 2011 and based in Miami, Florida, DadeSystems aims to streamline cash flow and automate accounts receivable processes for its clients.

BabySparks

Seed Round in 2019
BabySparks is a developer of tools and programs to help parents engage their babies and toddlers in the critical areas of early development. The company's early development program learns each child's unique profile, identifies specific needs, and provides meaningful activities to support them. The company was established in 2013 and is headquartered in Plantation, Florida.

Taxfyle

Series A in 2018
Tickmark dba Taxfyle develops accounting-based applications for iOS and Android platforms as well as newly designed web app. The company developed Taxfyle, to make tax calculations with ease. Taxfyle was founded in 2015 and is based in Miami, Florida.

Aegle Therapeutics

Seed Round in 2018
Aegle Therapeutics is a privately-held biotechnology company developing a first in class therapy using extracellular vesicles, including exosomes, secreted by allogeneic bone marrow-derived mesenchymal stem cells. Aegle's platform technology is initially being developed to treat dystrophic epidermolysis bullosa, a rare pediatric skin blistering disorder. Aegle's IND for DEB has been cleared by the FDA and the company expects to enter the clinic by the 2H of 2020. Its proprietary platform isolation technology is cell-free and has the potential to demonstrate a safer, lower-cost means of harnessing the regenerative healing power of stem cells without using the cells. Aegle believes its EV therapy has the potential for functional regeneration and organization of complex tissue structures that can enhance healing, reduce scarring, minimize contraction, and improve overall cosmesis. The company was founded in 2013 and is based in Miami, Florida.

DadeSystems

Series A in 2017
DadeSystems, LLP specializes in developing payment processing software solutions, particularly focused on cash application automation. Its flagship product, DadePay, is a SaaS-based platform that automates the complex invoice-to-cash process, efficiently capturing incoming payments through various channels such as cash, checks, ACH, EFT, and credit cards. DadePay employs advanced algorithms to match payments to open invoices, ensuring that updates are reflected in ERP systems and facilitating electronic deposits at banks. The suite includes additional features like DadePay Mobile for mobile payment matching and a customer ePayment portal. DadeSystems serves a diverse range of industries, including manufacturing, healthcare, retail, and financial institutions, helping them improve efficiency, reduce processing costs, and enhance customer payment experiences. Founded in 2011 and based in Miami, Florida, DadeSystems aims to streamline cash flow and automate accounts receivable processes for its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.